MedTrace Logo

Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination

NCT06103994 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-04-10

No results posted yet for this study

Summary

A randomized, triple-blinded, placebo-controlled, parallel group study, to assess the effect of multistrain probiotic on the immune response to the Influenza vaccination

Conditions

Interventions

DIETARY_SUPPLEMENT

Multistrain probiotic

Multistrain Probiotic

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • NEXT CRO

    collaborator UNKNOWN

  • The Archer-Daniels-Midland Company

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-27
Primary Completion
2024-01-12
Completion
2024-01-12

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06103994 on ClinicalTrials.gov